ritanserin has been researched along with irindalone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnt, J; Boeck, V; Bøgesø, KP; Christensen, AV; Hyttel, J; Jensen, KG | 1 |
| Andersen, K; Bøgesø, KP; Gundertofte, K; Liljefors, T; Perregaard, J | 1 |
| Arnt, J; Bøgesø, KP; Hyttel, J; Pedersen, H | 1 |
3 other study(ies) available for ritanserin and irindalone
| Article | Year |
|---|---|
Antihypertensive activity in a series of 1-piperazino-3-phenylindans with potent 5-HT2-antagonistic activity.
Topics: Animals; Antihypertensive Agents; Antipsychotic Agents; Blood Pressure; Chemical Phenomena; Chemistry; Dopamine; Imidazoles; Ketanserin; Norepinephrine; Phenylephrine; Piperazines; Rats; Rats, Inbred SHR; Serotonin Antagonists; Structure-Activity Relationship | 1988 |
Development of a receptor-interaction model for serotonin 5-HT2 receptor antagonists. Predicting selectivity with respect to dopamine D2 receptors.
Topics: Indans; Indoles; Models, Chemical; Molecular Conformation; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship | 1994 |
Stereospecific and selective 5-HT2 antagonism in a series of 5-substituted trans-1-piperazino-3-phenylindans.
Topics: Animals; Brain; Indans; Male; Piperazines; Rats; Rats, Wistar; Serotonin Antagonists; Stereoisomerism; Structure-Activity Relationship | 1993 |